Medios AG (ETR: ILM1)

Market Cap	300.00M
Revenue (ttm)	1.84B
Net Income (ttm)	12.88M
Shares Out	25.51M
EPS (ttm)	0.53
PE Ratio	22.12
Forward PE	8.99
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,337
Open	11.46
Previous Close	11.46
Day's Range	11.36 - 11.78
52-Week Range	11.24 - 18.50
Beta	1.08
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 28, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2016
• Employees: 515
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: ILM1

Financial Performance

In 2023, Medios AG's revenue was 1.78 billion, an increase of 10.71% compared to the previous year's 1.61 billion. Earnings were 18.81 million, an increase of 2.62%.